# OnCo record barbara-burtness (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/barbara-burtness/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "barbara-burtness" ;
  schema:name "Barbara Burtness"@en ;
  schema:description "Led KEYNOTE-048, which made pembrolizumab first-line therapy for recurrent or metastatic head and neck cancer."@en ;
  schema:url <https://onco.cc/people/barbara-burtness/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Barbara_Burtness>, <https://orcid.org/0000-0003-4660-1859> ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Burtness%20B%5BAuthor%5D%20head%20neck%20pembrolizumab> ;
  onco:tag "head-and-neck", "immunotherapy", "ecog-acrin" ;
  schema:jobTitle "Professor of Medicine and Co-Leader, Developmental Therapeutics, Yale Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/egfr/> ;
  onco:drugs <https://onco.cc/drugs/pembrolizumab/> ;
  onco:institutions <https://onco.cc/institutions/yale-cancer-center/> ;
  onco:trials <https://onco.cc/trials/keynote-048/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-keynote-048-lancet-2019/> ;
  schema:affiliation <https://onco.cc/institutions/yale-cancer-center/> .